Daniel S. Pine, M.D

Daniel S. Pine, M.D., is Chief, Section on Development and Affective Neuroscience in the National Institute of Mental Health (NIMH) Intramural Research Program. After graduating from medical school at the University of Chicago, Pine spent 10 years in training and research on child psychiatry at the College of Physicians and Surgeons of Columbia University. Since medical school, he has been engaged continuously in research focusing on the epidemiology, biology, and treatment of pediatric mental illnesses. His areas of expertise include biological and pharmacological aspects of mood, anxiety, and behavioral disorders in children, as well as classification of psychopathology across the lifespan. Pine has served as the chair of the psychopharmacologic drug advisory committee for the Food and Drug Administration and chair of the Child and Adolescent Diagnosis Group for the DSM-5 Task Force.  He has received the Joel Elkes Award from the American College of Neuropsychopharmacology, the Blanche Ittelson Award from the American Psychiatric Association, and the Ruane Prize from the Brain & Behavior Research Foundation.